Bolette Hartmann results 2
· Newest (Page 1/1, per page 25)
Author: Bolette Hartmann ×Clear All Filters
Search Results
Rationale Glucagon-like peptide-1 (GLP-1) receptor agonists reduce alcohol consumption in rodents and non-human primates. Semaglutide is a new long-acting GLP-1 receptor agonist, widely used in the clinic against type 2 diabetes and obesity. It is also reported to reduce alcohol intake in rodents. Objectives This study investigates the possible inhibitory effect of semaglutide on alcohol intake in alcohol-preferring African gr...
Previous1Next